| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/28/2004 | CN1136315C Purified polyporus laccases and nucleic acids encoding same |
| 01/28/2004 | CN1136311C Subtilase variants and compositions |
| 01/28/2004 | CN1135933C Multifunctional nutritive liquid and its production method |
| 01/28/2004 | CN1135925C Method for preparing biological rodenticide and composition obtained thereby |
| 01/27/2004 | US6683171 Contacting fkhsf specific nucleic acid probe under high stringency hybridizing conditions with at least one nucleic acid molecule from biological sample, detecting formation of hybrid, indicating presence of fkhsf nucleic acid molecule |
| 01/27/2004 | US6683161 Human ependymin |
| 01/27/2004 | US6683160 Antibodies specific for Fkhsf gene products |
| 01/27/2004 | US6683157 Variant human α7 acetylcholine receptor subunit, and methods of production and use thereof |
| 01/27/2004 | US6683155 Purified and isolated polypeptide comprising specified amino acid sequence; regulating degradation of extracellular matrix |
| 01/27/2004 | US6682925 Activity against beet armyworm and has minimal or no acaricidal activity against two-spotted spider mites |
| 01/27/2004 | US6682924 Protease variants and compositions |
| 01/27/2004 | US6682917 Rate-limiting enzyme, which converts ribonucleotides to their corresponding deoxyribonucleotides and supplies them for purposes of dna synthesis; drug comprising protein; kit for screening for modulators of protein activity |
| 01/27/2004 | US6682915 Fermentation of enterbacter |
| 01/27/2004 | US6682912 L-glutamic acid-producing bacterium and method for producing L-glutamic acid |
| 01/27/2004 | US6682910 Gene expression, incubation; genetic engineering |
| 01/27/2004 | US6682906 Cloned glutamic acid decarboxylase |
| 01/27/2004 | US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis |
| 01/27/2004 | US6682742 Vector for integration of heterologous sequences into poxviral genomes |
| 01/27/2004 | US6682730 Transplants for myocardial scars |
| 01/27/2004 | US6682729 Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same |
| 01/27/2004 | CA2002607C Natural killer stimulatory factor |
| 01/22/2004 | WO2004008103A2 Mutations of voltage-gated potassium channels |
| 01/22/2004 | WO2004007726A2 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | WO2004007723A2 Genes |
| 01/22/2004 | WO2004007719A1 Use of sumo- and ubiquitin-modified pcna for detection and channeling of dna transaction pathways |
| 01/22/2004 | WO2004007716A1 Method of isolating gpcr gene and novel gpcr gene |
| 01/22/2004 | WO2004007714A1 Human prothrombin analog and human meizothrombin analog |
| 01/22/2004 | WO2004007709A2 Production of polyketides |
| 01/22/2004 | WO2004007695A2 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 01/22/2004 | WO2004007684A2 Synthetic tag genes |
| 01/22/2004 | WO2004007670A2 RECOMBINANT TYPE II RESTRICTION ENDONUCLEASES, MmeI AND RELATED ENDONUCLEASES AND METHODS FOR PRODUCTING THE SAME |
| 01/22/2004 | WO2004007404A1 Mineral and bioorganic additive for plant growth and development |
| 01/22/2004 | WO2004006857A2 Glanders/meliodosis vaccines |
| 01/22/2004 | WO2004006855A2 Rhodococcus equi mutants and vaccines comprising same |
| 01/22/2004 | WO2004006851A2 Mycoplasma gallisepticum formulation |
| 01/22/2004 | WO2004006643A2 Environmentally safe agricultural supplement |
| 01/22/2004 | WO2003067213A3 Modulation of sulfate permease for photosynthetic hydrogen production |
| 01/22/2004 | WO2003066087A3 Kinases involved in the regulation of energy homeostasis |
| 01/22/2004 | WO2003064610A3 Mutant actinosynnema pretiosum strain with increased maytansinoid production |
| 01/22/2004 | WO2003048205A3 Novel proteins with il-6 inhibiting activity |
| 01/22/2004 | WO2003038106A3 A process for the production of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced fadr or iclr gene |
| 01/22/2004 | WO2003014386A3 Method for identifying macrocyclic polyketides |
| 01/22/2004 | WO2003014380A3 Microoroganisms and cells for diagnosis and therapy of tumors |
| 01/22/2004 | WO2003008614A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced suca or sucb gene |
| 01/22/2004 | WO2003008612A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced rsea or rsec gene |
| 01/22/2004 | WO2003004697A3 Method for detecting mutagenic substances |
| 01/22/2004 | WO2002099120A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/22/2004 | WO2002092814A3 Screening method for attenuating or virulence defective microbial cells |
| 01/22/2004 | US20040016020 DNA encoding insecticidal Cry1Bf Bacillus thuringiensis proteins and recombinant hosts expressing same |
| 01/22/2004 | US20040016006 Chromosome 3p21.3 genes are tumor suppressors |
| 01/22/2004 | US20040014954 Comprises nucleotide sequences coding secreted polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 01/22/2004 | US20040014942 Transformation cells by introduction of a false-sense mutation at a target codon of a gene coding for a protein necessary for the growth of the cells, such protein synthesized from the gene thus mutated is non functional |
| 01/22/2004 | US20040014937 Contacting alkene with microorganism which epoxidizes and converts alkene to carboxylic acid |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014221 Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method |
| 01/22/2004 | US20040014198 Non-revertible beta-oxidation blocked candida tropicalis |
| 01/22/2004 | US20040014197 Microbial strains and process for the manufacture of biomaterials |
| 01/22/2004 | US20040014196 Using dechloromonas to biodegrade/bioremediate benzene, toluene, xylene or ethylbenzene present in soils and water supplies |
| 01/22/2004 | US20040014195 Nitrilases have increased activity and stability at increased pH and temperature |
| 01/22/2004 | US20040014191 Comprises nucleotide sequences and viral vector coding nitroreductase for generating cytotoxic 4- hydroxylamine to treat cancer; site diredted mutagenesis; prodrugs; anticarcinogenic agents |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014183 Secondary metabolite congener distribution modulation |
| 01/22/2004 | US20040014180 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof |
| 01/22/2004 | US20040014179 Purifying and separating microorganisms from high molecular weight contaminants in fermentation broth; recovering hyaluronic acid |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014175 Producting proteases which differ from wild type in at least one amino acid for use in industrial and food applications such as textile treatment, detergents and protein degradation |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014170 Controlling formation of acidic sugar chain associated with heterologously expressed glycoproteins in pichia; preparing less antigenic polypeptides; pharmacology; drug design |
| 01/22/2004 | US20040014169 Novel G protein-coupled receptors |
| 01/22/2004 | US20040014167 Process for producing biopterin |
| 01/22/2004 | US20040014166 Process for producing substance by using microbial catalyst |
| 01/22/2004 | US20040014164 Dried composition comprised of glassy matrix for improving stability and storage of proteins |
| 01/22/2004 | US20040014163 Immunoassay mixture for measuring calcium-dependent glutamate dehydrogenase activities and treating bone, teeth and oral diseases |
| 01/22/2004 | US20040014158 Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 01/22/2004 | US20040014134 Two coloured fluorimetric protease assay |
| 01/22/2004 | US20040014132 Comprises immunoglobulins which binds and neutralizes chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040014123 Nucleotide sequences coding for the export of branched-chain amino acids, process for the isolation thereof and use thereof |
| 01/22/2004 | US20040014116 Plant caffeic acid 3-0-methyltransferase homologs |
| 01/22/2004 | US20040014110 Dendritic enriched secreted lymphocyte activation molecule |
| 01/22/2004 | US20040014092 Production of transgenic plants which synthesize long-chain inulin due to the introduction of nucleic acid molecules encoding a fructosyl transferase |
| 01/22/2004 | US20040014089 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 01/22/2004 | US20040014072 Novel dna synthase |
| 01/22/2004 | US20040014055 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/22/2004 | US20040014052 Process for regulating gene expression |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040013739 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 01/22/2004 | US20040013690 Attenuated Listeria spp. and methods for using the same |
| 01/22/2004 | US20040013689 Prevention, therapy infectious diseases; insertion of nucleic acids into target cells |
| 01/22/2004 | US20040013686 Surface exposure epitope of loops of Neisseria; induction antibodies; competitive binding |
| 01/22/2004 | US20040013685 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013651 Agents and method of controlling plant foliage diseases |
| 01/22/2004 | US20040013648 Vector system |
| 01/22/2004 | US20040011485 Process for bio-bleaching of kraft pulp using bacterial consortia |
| 01/22/2004 | CA2621517A1 Production of polyketides fkbp-ligand analogues |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2492856A1 Rhodococcus equi mutants and vaccines comprising same |